This website requires certain cookies to work and uses other cookies to help you have the best experience. By visiting this website, certain cookies have already been set, which you may delete and block. By closing this message or continuing to use our site, you agree to the use of cookies. Visit our updated privacy and cookie policy to learn more.
This Website Uses Cookies By closing this message or continuing to use our site, you agree to our cookie policy. Learn MoreThis website requires certain cookies to work and uses other cookies to help you have the best experience. By visiting this website, certain cookies have already been set, which you may delete and block. By closing this message or continuing to use our site, you agree to the use of cookies. Visit our updated privacy and cookie policy to learn more.
InMed Pharmaceuticals Inc. has launched B2B sales of delta-9-dominant tetrahydrocannabivarin (THCV) into the health and wellness sector via its wholly-owned subsidiary, BayMedica LLC.
Vertosa has entered into a research partnership with the University of Massachusetts Amherst to support the university’s studies regarding the nutritional applications and diet interactions of CBG.
Sales of foods and beverages infused with delta-8-THC are exploding, creating concerns regarding these untested and unregulated products’ safety and potency.
Protecting Your Investment: Developers and processors of cannabinoid-infused foods and beverages have options to increase stability and shelf life of these high-value products.